Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation

View ORCID ProfileNan Chiang, View ORCID ProfileXavier de la Rosa, View ORCID ProfileStephania Libreros, View ORCID ProfileHui Pan, View ORCID ProfileJonathan M. Dreyfuss, and View ORCID ProfileCharles N. Serhan
  1. aDepartment of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;
  2. bBioinformatics & Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115

See allHide authors and affiliations

PNAS March 9, 2021 118 (10) e2013374118; https://doi.org/10.1073/pnas.2013374118
Nan Chiang
aDepartment of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nan Chiang
Xavier de la Rosa
aDepartment of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xavier de la Rosa
Stephania Libreros
aDepartment of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephania Libreros
Hui Pan
bBioinformatics & Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hui Pan
Jonathan M. Dreyfuss
bBioinformatics & Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan M. Dreyfuss
Charles N. Serhan
aDepartment of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charles N. Serhan
  • For correspondence: cserhan@bwh.harvard.edu
  1. Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved January 14, 2021 (received for review June 26, 2020)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

Resolution of inflammation, infection, and injury are essential for host defense and homeostasis. Cysteinyl-specialized proresolving mediators (cys-SPMs) are potent chemical signals that accelerate resolution of inflammation, control infection, and display proregenerative properties. We sought evidence for cys-SPM–activated primordial pathways that might link resolution of inflammation and regeneration using planaria because of their robust regenerative ability. RNA sequencing was carried out with surgically resected planaria exposed to cys-SPMs, and we identified genes and pathways regulated by cys-SPMs during the regeneration, including TRAF3. In mammalian systems, TRAF3 contributes to cys-SPM–stimulated phagocyte functions and resolution of infection.

Abstract

The recently elucidated proresolving conjugates in tissue regeneration (CTR) maresin-CTR (MCTR), protectin-CTR (PCTR), and resolvin-CTR (RCTR), termed cysteinyl-specialized proresolving mediators (cys-SPMs) each promotes regeneration, controls infection, and accelerates resolution of inflammation. Here, we sought evidence for cys-SPM activation of primordial pathways in planaria (Dugesia japonica) regeneration that might link resolution of inflammation and regeneration. On surgical resection, planaria regeneration was enhanced with MCTR3, PCTR3, or RCTR3 (10 nM), each used for RNA sequencing. The three cys-SPMs shared up-regulation of 175 known transcripts with fold-change > 1.25 and combined false discovery rate (FDR) < 0.002, and 199 canonical pathways (FDR < 0.25), including NF-κB pathways and an ortholog of human TRAF3 (TNFR-associated factor 3). Three separate pathway analyses converged on TRAF3 up-regulation by cys-SPMs. With human macrophages, three cys-SPMs each dose-dependently increased TRAF3 expression in a cAMP-PKA–dependent manner. TRAF3 overexpression in macrophages enhanced Interleukin-10 (IL-10) and phagocytosis of Escherichia coli. IL-10 also increased phagocytosis in a dose-dependent manner. Silencing of mouse TRAF3 in vivo significantly reduced IL-10 and macrophage phagocytosis. TRAF3 silencing in vivo also relieved cys-SPMs’ actions in limiting polymorphonuclear neutrophil in E. coli exudates. These results identify cys-SPM–regulated pathways in planaria regeneration, uncovering a role for TRAF3/IL-10 in regulating mammalian phagocyte functions in resolution. Cys-SPM activation of TRAF3 signaling is a molecular component of both regeneration and resolution of infectious inflammation.

  • leukocytes
  • resolvins
  • planaria
  • chemical mediators
  • signaling

Footnotes

  • ↵1To whom correspondence may be addressed. Email: cserhan{at}bwh.harvard.edu.
  • Author contributions: N.C. and C.N.S. designed research; N.C., X.d.l.R., and S.L. performed research; N.C., X.d.l.R., S.L., and C.N.S. analyzed data; H.P. and J.M.D. carried out bioinformatics; and N.C. and C.N.S. wrote the paper.

  • The authors declare no competing interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2013374118/-/DCSupplemental.

Data Availability

The planaria RNA-seq data have been deposited in the Gene Expression Omnibus (GEO) database, https://www.ncbi.nlm.nih.gov/geo (accession no. GSE160278).

Published under the PNAS license.

View Full Text

References

  1. ↵
    1. C. N. Serhan,
    2. J. Savill
    , Resolution of inflammation: The beginning programs the end. Nat. Immunol. 6, 1191–1197 (2005).
    OpenUrlCrossRefPubMed
  2. ↵
    1. A. G. Rossi,
    2. D. A. Sawatzky
    , Eds., The Resolution of Inflammation (Birkhäuser Verlag AG, Basel, 2008).
  3. ↵
    1. S. Gordon
    , Ed., Myeloid Cells in Health and Disease: A Synthesis (ASM Press, Washington, DC, 2017).
  4. ↵
    1. S. J. Forbes,
    2. N. Rosenthal
    , Preparing the ground for tissue regeneration: From mechanism to therapy. Nat. Med. 20, 857–869 (2014).
    OpenUrlCrossRefPubMed
  5. ↵
    1. J. A. Cartwright,
    2. C. D. Lucas,
    3. A. G. Rossi
    , Inflammation resolution and the induction of granulocyte apoptosis by cyclin-dependent kinase inhibitor drugs. Front. Pharmacol. 10, 55 (2019).
    OpenUrl
  6. ↵
    1. W. M. Nauseef,
    2. N. Borregaard
    , Neutrophils at work. Nat. Immunol. 15, 602–611 (2014).
    OpenUrlCrossRefPubMed
  7. ↵
    1. Y. Okabe,
    2. R. Medzhitov
    , Tissue biology perspective on macrophages. Nat. Immunol. 17, 9–17 (2016).
    OpenUrlCrossRefPubMed
  8. ↵
    1. O. Soehnlein,
    2. S. Steffens,
    3. A. Hidalgo,
    4. C. Weber
    , Neutrophils as protagonists and targets in chronic inflammation. Nat. Rev. Immunol. 17, 248–261 (2017).
    OpenUrlCrossRefPubMed
  9. ↵
    1. C. N. Serhan,
    2. N. Chiang,
    3. J. Dalli
    , New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol. Aspects Med. 64, 1–17 (2018).
    OpenUrl
  10. ↵
    1. M. G. Padovan,
    2. L. V. Norling
    , Pro-resolving lipid mediators in sepsis and critical illness. Curr. Opin. Clin. Nutr. Metab. Care 23, 76–81 (2020).
    OpenUrl
  11. ↵
    1. M. S. Conte,
    2. T. A. Desai,
    3. B. Wu,
    4. M. Schaller,
    5. E. Werlin
    , Pro-resolving lipid mediators in vascular disease. J. Clin. Invest. 128, 3727–3735 (2018).
    OpenUrl
  12. ↵
    1. G. Fredman,
    2. I. Tabas
    , Boosting inflammation resolution in atherosclerosis: The next frontier for therapy. Am. J. Pathol. 187, 1211–1221 (2017).
    OpenUrl
  13. ↵
    1. J. Pirault,
    2. M. Bäck
    , Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease. Front. Pharmacol. 9, 1273 (2018).
    OpenUrl
  14. ↵
    1. T. Liu et al
    ., HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 116, 23254–23263 (2019).
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. C. López-Vicario et al
    ., Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals. Sci. Rep. 7, 15724 (2017).
    OpenUrl
  16. ↵
    1. M. Zhu,
    2. X. Wang,
    3. L. Sun,
    4. M. Schultzberg,
    5. E. Hjorth
    , Can inflammation be resolved in Alzheimer’s disease? Ther. Adv. Neurol. Disord. 11, 1756286418791107 (2018).
    OpenUrl
  17. ↵
    1. R. Doyle,
    2. D. M. Sadlier,
    3. C. Godson
    , Pro-resolving lipid mediators: Agents of anti-ageing? Semin. Immunol. 40, 36–48 (2018).
    OpenUrl
  18. ↵
    1. M. Sekheri,
    2. D. El Kebir,
    3. N. Edner,
    4. J. G. Filep
    , 15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation. Proc. Natl. Acad. Sci. U.S.A. 117, 7971–7980 (2020).
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. S. P. Colgan
    , Resolvins resolve to heal mucosal wounds. Proc. Natl. Acad. Sci. U.S.A. 117, 10621–10622 (2020).
    OpenUrlFREE Full Text
  20. ↵
    1. N. Giannakis et al
    ., Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration. Nat. Immunol. 20, 626–636 (2019).
    OpenUrlCrossRefPubMed
  21. ↵
    1. X. de la Rosa et al
    ., Identification and complete stereochemical assignments of the new resolvin conjugates in tissue regeneration (RCTR) in human tissues that stimulate proresolving phagocyte functions and tissue regeneration. Am. J. Pathol. 188, 950–966 (2018).
    OpenUrl
  22. ↵
    1. C. Godson
    , Balancing the effect of leukotrienes in asthma. N. Engl. J. Med. 382, 1472–1475 (2020).
    OpenUrl
  23. ↵
    1. B. D. Levy et al
    ., Cysteinyl maresins regulate the prophlogistic lung actions of cysteinyl leukotrienes. J. Allergy Clin. Immunol. 145, 335–344 (2020).
    OpenUrl
  24. ↵
    1. S. Liening,
    2. E. Romp,
    3. O. Werz,
    4. G. K. E. Scriba,
    5. U. Garscha
    , Liquid chromatography-coupled mass spectrometry analysis of glutathione conjugates of oxygenated polyunsaturated fatty acids. Prostaglandins Other Lipid Mediat. 144, 106350 (2019).
    OpenUrl
  25. ↵
    1. Q. Wang et al
    ., MCTR1 enhances the resolution of lipopolysaccharide-induced lung injury through STAT6-mediated resident M2 alveolar macrophage polarization in mice. J. Cell. Mol. Med. 24, 9646–9657 (2020).
    OpenUrl
  26. ↵
    1. P. H. Zhang et al
    ., PCTR1 improves pulmonary edema fluid clearance through activating the sodium channel and lymphatic drainage in lipopolysaccharide-induced ARDS. J. Cell. Physiol. 235, 9510–9523 (2020).
    OpenUrl
  27. ↵
    1. A. Sánchez Alvarado
    , Planarian regeneration: Its end is its beginning. Cell 124, 241–245 (2006).
    OpenUrlCrossRefPubMed
  28. ↵
    1. Y. Y. Li et al
    ., Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. Nat. Commun. 8, 14121 (2017).
    OpenUrlCrossRefPubMed
  29. ↵
    1. A. J. Sadler et al
    ., The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZF. Nat. Commun. 6, 6795 (2015).
    OpenUrlCrossRef
  30. ↵
    1. A. I. Lalani et al
    ., Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice. J. Immunol. 194, 334–348 (2015).
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. H. Häcker et al
    ., Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204–207 (2006).
    OpenUrlCrossRefPubMed
  32. ↵
    1. H. Häcker,
    2. P. H. Tseng,
    3. M. Karin
    , Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11, 457–468 (2011).
    OpenUrlCrossRefPubMed
  33. ↵
    1. R. Oughtred et al
    ., The BioGRID interaction database: 2019 update. Nucleic Acids Res. 47, D529–D541 (2019).
    OpenUrlCrossRefPubMed
  34. ↵
    1. J. Dalli,
    2. N. Chiang,
    3. C. N. Serhan
    , Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection. Proc. Natl. Acad. Sci. U.S.A. 111, E4753–E4761 (2014).
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Sok et al
    ., Dual delivery of IL-10 and AT-RvD1 from PEG hydrogels polarize immune cells towards pro-regenerative phenotype. Biomaterials 268, 120475 (2020).
    OpenUrl
  36. ↵
    1. J. Bystrom et al
    ., Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112, 4117–4127 (2008).
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. R. A. Engh,
    2. A. Girod,
    3. V. Kinzel,
    4. R. Huber,
    5. D. Bossemeyer
    , Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity. J. Biol. Chem. 271, 26157–26164 (1996).
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. W. A. Sands,
    2. T. M. Palmer
    , Regulating gene transcription in response to cyclic AMP elevation. Cell. Signal. 20, 460–466 (2008).
    OpenUrlCrossRefPubMed
  39. ↵
    1. T. Liu et al
    ., Cistrome: An integrative platform for transcriptional regulation studies. Genome Biol. 12, R83 (2011).
    OpenUrlCrossRefPubMed
  40. ↵
    1. F. Bazzoni,
    2. N. Tamassia,
    3. M. Rossato,
    4. M. A. Cassatella
    , Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: Lessons from neutrophils. Eur. J. Immunol. 40, 2360–2368 (2010).
    OpenUrlCrossRefPubMed
  41. ↵
    1. M. J. Kang et al
    ., IL-10 protects mice from the lung infection of Acinetobacter baumannii and contributes to bacterial clearance by regulating STAT3-mediated MARCO expression in macrophages. Front. Immunol. 11, 270 (2020).
    OpenUrlCrossRefPubMed
  42. ↵
    1. Y. Umesono et al
    ., The molecular logic for planarian regeneration along the anterior-posterior axis. Nature 500, 73–76 (2013).
    OpenUrlCrossRefPubMed
  43. ↵
    1. J. M. Calandria et al
    ., NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival. Cell Death Differ. 22, 1363–1377 (2015).
    OpenUrlCrossRef
  44. ↵
    1. Q. Pang et al
    ., De novo transcriptome analysis provides insights into immune related genes and the RIG-I-like receptor signaling pathway in the freshwater planarian (Dugesia japonica). PLoS One 11, e0151597 (2016).
    OpenUrlCrossRef
  45. ↵
    1. J. McGowan et al
    ., 14-3-3ζ-TRAF5 axis governs interleukin-17A signaling. Proc. Natl. Acad. Sci. U.S.A. 117, 25008–25017 (2020).
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. T. Schumacher et al
    ., ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice. PLoS One 7, e35613 (2012).
    OpenUrlCrossRefPubMed
  47. ↵
    1. S. Kim,
    2. A. Hill,
    3. M. L. Warman,
    4. P. Smits
    , Golgi disruption and early embryonic lethality in mice lacking USO1. PLoS One 7, e50530 (2012).
    OpenUrlCrossRefPubMed
  48. ↵
    1. I. Mitxitorena et al
    ., The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits. J. Biol. Chem. 295, 11754–11763 (2020).
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Y. M. Ohol et al
    ., Novel, selective inhibitors of USP7 uncover multiple mechanisms of antitumor activity in vitro and in vivo. Mol. Cancer Ther. 19, 1970–1980 (2020).
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. J. Luo et al
    ., OTUD5 regulates p53 stability by deubiquitinating p53. PLoS One 8, e77682 (2013).
    OpenUrlCrossRefPubMed
  51. ↵
    1. S. Michlewska,
    2. I. Dransfield,
    3. I. L. Megson,
    4. A. G. Rossi
    , Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: Key role for TNF-alpha. FASEB J. 23, 844–854 (2009).
    OpenUrlCrossRefPubMed
  52. ↵
    1. C. Z. Ni et al
    ., Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. U.S.A. 97, 10395–10399 (2000).
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. A. B. Dash et al
    ., Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-κB pathway activation. Eur. J. Haematol. 105, 274–285 (2020).
    OpenUrl
  54. ↵
    1. R. Zhang et al
    ., TRAF3 negatively regulates platelet activation and thrombosis. Sci. Rep. 7, 17112 (2017).
    OpenUrl
  55. ↵
    1. D. C. Beachboard et al
    ., The small GTPase RAB1B promotes antiviral innate immunity by interacting with TNF receptor-associated factor 3 (TRAF3). J. Biol. Chem. 294, 14231–14240 (2019).
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. W. Zhu et al
    ., TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity. EMBO J. 38, e102075 (2019).
    OpenUrl
  57. ↵
    1. D. Cherpokova et al
    ., Resolvin D4 attenuates the severity of pathological thrombosis in mice. Blood 134, 1458–1468 (2019).
    OpenUrl
  58. ↵
    1. B. Diamond
    , The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications. J. Exp. Med. 217, e20201000 (2020).
    OpenUrl
  59. ↵
    1. D. Giannis,
    2. I. A. Ziogas,
    3. P. Gianni
    , Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J. Clin. Virol. 127, 104362 (2020).
    OpenUrlCrossRefPubMed
  60. ↵
    1. L. P. Sousa,
    2. V. Pinho,
    3. M. M. Teixeira
    , Harnessing resolving-based therapeutics to treat pulmonary viral infections: What can the future offer to COVID-19? Br. J. Pharmacol. 177, 3898–3904 (2020).
    OpenUrl
  61. ↵
    1. A. Recchiuti et al
    ., Resolvin D1 and D2 reduce SARS-Cov-2-induced inflammation in cystic fibrosis macrophages. bioRxiv:10.1101/2020.08.28.255463 (28 August 2020).
  62. ↵
    1. B. Schwarz et al
    ., Cutting edge: Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators. J. Immunol. 206, 329–334 (2021).
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. P. Horby et al.; RECOVERY Collaborative Group
    , Dexamethasone in hospitalized patients with Covid-19—Preliminary report. N. Engl. J. Med., doi:10.1056/NEJMoa2021436 (2020).
    OpenUrlCrossRefPubMed
  64. ↵
    1. K. Pyrillou,
    2. A. D. Chairakaki,
    3. C. Tamvakopoulos,
    4. E. Andreakos
    , Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation. J. Allergy Clin. Immunol. 142, 691–695.e4 (2018).
    OpenUrl
  65. ↵
    1. A. Recchiuti,
    2. S. Krishnamoorthy,
    3. G. Fredman,
    4. N. Chiang,
    5. C. N. Serhan
    , MicroRNAs in resolution of acute inflammation: Identification of novel resolvin D1-miRNA circuits. FASEB J. 25, 544–560 (2011).
    OpenUrlCrossRefPubMed
  66. ↵
    1. N. Chiang et al
    ., Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524–528 (2012).
    OpenUrlCrossRefPubMed
  67. ↵
    1. H. P. Sham et al
    ., 15-epi-Lipoxin A4, resolvin D2, and resolvin D3 induce NF-κB regulators in bacterial pneumonia. J. Immunol. 200, 2757–2766 (2018).
    OpenUrlAbstract/FREE Full Text
  68. ↵
    1. B. Samuelsson
    , Role of basic science in the development of new medicines: Examples from the eicosanoid field. J. Biol. Chem. 287, 10070–10080 (2012).
    OpenUrlAbstract/FREE Full Text
  69. ↵
    1. N. L. Bray,
    2. H. Pimentel,
    3. P. Melsted,
    4. L. Pachter
    , Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
    OpenUrlCrossRefPubMed
  70. ↵
    1. J. D. Chan et al
    ., Dataset for a Dugesia japonica de novo transcriptome assembly, utilized for defining the voltage-gated like ion channel superfamily. Data Brief 9, 1044–1047 (2016).
    OpenUrl
  71. ↵
    1. J. Huerta-Cepas et al
    ., eggNOG 4.5: A hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences. Nucleic Acids Res. 44, D286–D293 (2016).
    OpenUrlCrossRefPubMed
  72. ↵
    1. H. Pimentel,
    2. N. L. Bray,
    3. S. Puente,
    4. P. Melsted,
    5. L. Pachter
    , Differential analysis of RNA-seq incorporating quantification uncertainty. Nat. Methods 14, 687–690 (2017).
    OpenUrlCrossRefPubMed
  73. ↵
    1. J. J. Goeman,
    2. P. Bühlmann
    , Analyzing gene expression data in terms of gene sets: Methodological issues. Bioinformatics 23, 980–987 (2007).
    OpenUrlCrossRefPubMed

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Subscribers, for more details, please visit our Subscriptions FAQ.

Please click here to log into the PNAS submission website.

PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation
Nan Chiang, Xavier de la Rosa, Stephania Libreros, Hui Pan, Jonathan M. Dreyfuss, Charles N. Serhan
Proceedings of the National Academy of Sciences Mar 2021, 118 (10) e2013374118; DOI: 10.1073/pnas.2013374118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation
Nan Chiang, Xavier de la Rosa, Stephania Libreros, Hui Pan, Jonathan M. Dreyfuss, Charles N. Serhan
Proceedings of the National Academy of Sciences Mar 2021, 118 (10) e2013374118; DOI: 10.1073/pnas.2013374118
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Biological Sciences
  • Immunology and Inflammation
Proceedings of the National Academy of Sciences: 118 (10)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Data Availability
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Reflection of clouds in the still waters of Mono Lake in California.
Inner Workings: Making headway with the mysteries of life’s origins
Recent experiments and simulations are starting to answer some fundamental questions about how life came to be.
Image credit: Shutterstock/Radoslaw Lecyk.
Cave in coastal Kenya with tree growing in the middle.
Journal Club: Small, sharp blades mark shift from Middle to Later Stone Age in coastal Kenya
Archaeologists have long tried to define the transition between the two time periods.
Image credit: Ceri Shipton.
Mouse fibroblast cells. Electron bifurcation reactions keep mammalian cells alive.
Exploring electron bifurcation
Jonathon Yuly, David Beratan, and Peng Zhang investigate how electron bifurcation reactions work.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490